NOT A CURE-ALL: Is tokenisation the solution for data sharing?
The DPO Centre
43:27
Clinical research teams are under increased pressure to get more value from trial data. It needs to be shared responsibly, reused where appropriate, and stored in a way that supports research in the future. At the same time, organisations must protect sensitive health data and meet strict legal obligations such as those set out in the General Data Protection Regulation (GDPR).
In this session, we discuss the different ways organisations can protect data when sharing it, including pseudonymisation, anonymisation, and tokenisation. We will also explore how data sharing in the Life Sciences sector is evolving. Large scale research collaborations and new regulatory frameworks such as the European Health Data Space are raising expectations for responsible secondary use and stronger governance.
Join Ben Seretny, COO, Lawrence Carter DPO and Life Sciences Sector Lead and Pippa Scotcher, DPO from The DPO Centre for a fireside chat about the benefits, challenges, and practical steps of data sharing in the Life Sciences, including:
- How is tokenisation being deployed in industry and how is this likely to expand?
- Practical considerations when sharing clinical trial and health data
- Tips and advice on preparing for the future
Speakers
Lawrence Carter
Life Sciences Sector Lead & Data Protection Officer at The DPO Centre
Lawrence Carter is a highly accomplished Data Protection Officer (DPO) and the Life Sciences Sector Lead at The DPO Centre. As a Subject Matter Expert in clinical trials, healthcare, and information governance, he helps organisations meet the highest standards of EU and UK data protection law. Lawrence supports global sponsors in multi-jurisdictional studies, advising on secondary data use and the impact of AI in research, and helping ensure compliance supports both regulation and innovation.
Pippa Scotcher
DPO at The DPO Centre
Pippa is a highly qualified Data Protection Officer with a background in law and specialist expertise in Life Sciences. She combines analytical precision with a pragmatic approach, helping global sponsors navigate the complex intersection of data protection law and clinical trial regulations. Pippa stays at the forefront of international privacy developments, offering valuable insights and guidance that help organisations strengthen accountability and achieve compliance excellence.
Replays
See all
NOT A CURE-ALL: Is tokenisation the solution for data sharing?
43:27